目次

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Indication
1.2.2. Application
1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Value-Chain-Based Sizing & Forecasting
1.7.3. Multivariate Model Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. mRNA Therapeutics Contract Development & Manufacturing Organization Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rapid adoption of mRNA in vaccine development
3.2.1.2. Multiple research efforts on mRNA therapeutics
3.2.1.3. Major funding for mRNA research
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of low-cost substitute therapies
3.2.2.2. High research cost
3.3. Pricing Model Analysis
3.4. Technology Landscape
3.5. Market Analysis Tools
3.5.1. Porter’s Five Force Analysis
3.5.2. PESTEL by SWOT Analysis
3.5.3. COVID-19 Impact Analysis

Chapter 4. mRNA Therapeutics Contract Development & Manufacturing Organization Market: Indication Estimates & Trend Analysis
4.1. mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Indication: Segment Dashboard
4.2. mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Indication: Movement Analysis
4.3. mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates & Forecasts, By Indication, 2021 - 2033 (USD Million)
4.4. Infectious Diseases
4.4.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Metabolic & Genetic Diseases
4.5.1. Metabolic & Genetic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Cardiovascular & Cerebrovascular Diseases
4.6.1. Cardiovascular & Cerebrovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. mRNA Therapeutics Contract Development & Manufacturing Organization Market: Application Estimates & Trend Analysis
5.1. mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Application: Segment Dashboard
5.2. mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Application: Movement Analysis
5.3. mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates & Forecasts, By Application, 2021 - 2033 (USD Million)
5.4. Viral Vaccines
5.4.1. Viral Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Protein Replacement Therapies
5.5.1. Protein Replacement Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Cancer Immunotherapies
5.6.1. Cancer Immunotherapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. mRNA Therapeutics Contract Development & Manufacturing Organization Market: End Use Estimates & Trend Analysis
6.1. mRNA Therapeutics Contract Development & Manufacturing Organization Market, By End Use: Segment Dashboard
6.2. mRNA Therapeutics Contract Development & Manufacturing Organization Market, By End Use: Movement Analysis
6.3. mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
6.4. Biotech Companies
6.4.1. Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Pharmaceutical companies
6.5.1. Pharmaceutical companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Government & Academic Research Institutes
6.6.1. Government & Academic Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. mRNA Therapeutics Contract Development & Manufacturing Organization Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2033
7.3. North America
7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. U.S
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Europe
7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Framework
7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Framework
7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.5. Thailand
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.6. South Korea
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. Australia
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Latin America
7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. MEA
7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Share/Assessment Analysis, 2024
8.3. Company Profiles
8.3.1. Danaher (Aldevron)
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Biomay AG
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Bio-Synthesis, Inc.
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. eTheRNA
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Kaneka Eurogentec S.A.
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. TriLink BioTechnologies
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. ApexBio Technology
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. BioNTech SE
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Biocina
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Lonza
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Recipharm AB
8.3.11.1. Company Overview
8.3.11.2. Financial Performance
8.3.11.3. Service Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Novo Holdings (Catalent, Inc.)
8.3.12.1. Company Overview
8.3.12.2. Financial Performance
8.3.12.3. Service Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. Samsung Biologics
8.3.13.1. Company Overview
8.3.13.2. Financial Performance
8.3.13.3. Service Benchmarking
8.3.13.4. Strategic Initiatives

List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 4. Global mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 5. Global mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 6. Global mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
Table 7. North America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 8. North America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 9. North America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 10. North America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 11. U.S. mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 12. U.S. mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 13. U.S. mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 14. Canada mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 15. Canada mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 16. Canada mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 17. Mexico mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 18. Mexico mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 19. Mexico mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 20. Europe mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 21. Europe mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 22. Europe mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 23. Europe mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 24. UK mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 25. UK mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 26. UK mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 27. Germany mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 28. Germany mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 29. Germany mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 30. France mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 31. France mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 32. France mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 33. Italy mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 34. Italy mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 35. Italy mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 36. Spain mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 37. Spain mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 38. Spain mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 39. Denmark mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 40. Denmark mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 41. Denmark mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 42. Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 43. Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 44. Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 45. Norway mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 46. Norway mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 47. Norway mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 48. Asia Pacific mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 49. Asia Pacific mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 50. Asia Pacific mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 51. Asia Pacific mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 52. Japan mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 53. Japan mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 54. Japan mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 55. China mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 56. China mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 57. China mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 58. India mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 59. India mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 60. India mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 61. Thailand mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 62. Thailand mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 63. Thailand mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 64. South Korea mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 65. South Korea mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 66. South Korea mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 67. Australia mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 68. Australia mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 69. Australia mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 70. Latin America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 71. Latin America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 72. Latin America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 73. Latin America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 74. Brazil mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 75. Brazil mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 76. Brazil mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 77. Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 78. Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 79. Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 80. Middle East & Africa mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 81. Middle East & Africa mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 82. Middle East & Africa mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 83. Middle East & Africa mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 84. South Africa mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 85. South Africa mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 86. South Africa mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 87. Saudi Arabia mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 88. Saudi Arabia mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 89. Saudi Arabia mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 90. UAE mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 91. UAE mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 92. UAE mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 93. Kuwait mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Indication, 2021 - 2033 (USD Million)
Table 94. Kuwait mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
Table 95. Kuwait mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 mRNA Therapeutics Contract Development & Manufacturing Organization Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 mRNA Therapeutics Contract Development & Manufacturing Organization Market: Indication outlook and key takeaways
Fig. 20 mRNA Therapeutics Contract Development & Manufacturing Organization Market: Indication movement analysis
Fig. 21 Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 22 Metabolic & Genetic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 23 Cardiovascular & Cerebrovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 24 mRNA Therapeutics Contract Development & Manufacturing Organization Market: Application outlook and key takeaways
Fig. 25 mRNA Therapeutics Contract Development & Manufacturing Organization Market: Application movement analysis
Fig. 26 Viral Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 27 Protein Replacement Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 28 Cancer Immunotherapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 29 mRNA Therapeutics Contract Development & Manufacturing Organization Market: End Use outlook and key takeaways
Fig. 30 mRNA Therapeutics Contract Development & Manufacturing Organization Market: End Use movement analysis
Fig. 31 Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 32 Pharmaceutical companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 33 Government & Academic Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 34 Regional Marketplace: Key Takeaways
Fig. 35 North America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 36 Key country dynamics
Fig. 37 U.S. mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 38 Key country dynamics
Fig. 39 Canada mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 Mexico mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 42 Europe mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 UK mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Germany mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 France mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Italy mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Spain mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Denmark mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Norway mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 59 Asia Pacific mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Japan mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 China mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 India mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Thailand mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 South Korea mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Australia mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 72 Latin America mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Brazil mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Argentina mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 77 MEA mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 South Africa mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Saudi Arabia mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 UAE mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Kuwait mRNA Therapeutics Contract Development & Manufacturing Organization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 86 Key company categorization
Fig. 87 Service heat map analysis
Fig. 88 Strategic framework